DAPK3 | Death-associated protein kinase 3 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK2 | Doublecortin-like kinase 2 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
DCLK3 | Doublecortin-like kinase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DDR1 | Discoidin domain receptor tyrosine kinase 1 | CD markers Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DSTYK | Dual serine/threonine and tyrosine protein kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DYRK1B | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DYRK2 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
EEF2K | Eukaryotic elongation factor-2 kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF2AK1 | Eukaryotic translation initiation factor 2-alpha kinase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
EIF2AK2 | Eukaryotic translation initiation factor 2-alpha kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EIF2AK4 | Eukaryotic translation initiation factor 2 alpha kinase 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
EPHA1 | EPH receptor A1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EPHA10 | EPH receptor A10 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHA3 | EPH receptor A3 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EPHA4 | EPH receptor A4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EPHA6 | EPH receptor A6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EPHA7 | EPH receptor A7 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EPHA8 | EPH receptor A8 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPHB2 | EPH receptor B2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EPHB4 | EPH receptor B4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ERN1 | Endoplasmic reticulum to nucleus signaling 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FASTK | Fas-activated serine/threonine kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FES | FES proto-oncogene, tyrosine kinase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FGFR1 | Fibroblast growth factor receptor 1 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGR | FGR proto-oncogene, Src family tyrosine kinase | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FRK | Fyn-related Src family tyrosine kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FYN | FYN proto-oncogene, Src family tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GAK | Cyclin G associated kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GRK4 | G protein-coupled receptor kinase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
GRK5 | G protein-coupled receptor kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |